PTC Therapeutics

PTC Therapeutics Gains Key Canadian Approval for Metabolic Disorder Drug

Brett Shapiro - December 11, 2025

PTC Therapeutics Stock Soars on Exceptional Quarterly Performance

November 18, 2025